X
Record #68262

Corrigendum: Natural killer cell-derived exosomal miR-3607-3p inhibits pancreatic cancer progression by targeting IL-26

Publisher
Frontiers
Original paper date
Dec 10, 2019
Institution
Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China · Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, Center of Precision Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China · Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China · Singlera Genomics Inc., San Diego, CA, United States · Singlera Genomics (Shanghai) Ltd., Shanghai, China · Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, Precision Medical Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
Open access
No
Broad categories
(BLS) Biology - Cellular(BLS) Genetics(HSC) Medicine - Gastroenterology(HSC) Medicine - Oncology
Notes from Retraction Watch

See also: https://pubpeer.com/publications/746BE98E8717FCB3E3EA856D35BC55 Original paper also retracted at same time as correction, see doi: 10.3389/fimmu.2024.1480124

Citation lifecycle

How this paper is being cited

Pre-retraction
1
Same day
0
Post-retraction
1
% post-retraction
50.0%
~0.2 citations/yr before retraction · ~0.5 citations/yr after
— citing papers

Who is still citing this work

Loading…
Back to browse